John Hancock Multifactor Developed International ETF
JHMD - ETF AI Analysis
Top Page
John Hancock Multifactor Developed International ETF (JHMD)
JHMD, the John Hancock Multifactor Developed International ETF, earns a solid overall rating thanks to several high-quality global leaders like Novartis, HSBC, ASML, and Nestlé, which bring strong financial performance, robust profitability, and generally supportive technical trends to the portfolio. However, weaker names such as Bayer, which faces financial challenges and valuation concerns, slightly weigh on the fund’s quality, and investors should note the main risk is its reliance on large international companies where occasional overvaluation and overbought conditions can add volatility.
JHMD vs. SPDR S&P 500 ETF (SPY)
- AUM
- 999.00M
- Region
- Developed Markets
- Expense Ratio
- 0.39%
- Beta
- 0.71
- Issuer
- John Hancock
- Inception Date
- Dec 15, 2016
- Dividend Yield
- 3.03%
- Asset Class
- Equity
- Index Tracked
- John Hancock Dimensional Developed International Index
JHMD Summary
JHMD is the John Hancock Multifactor Developed International ETF, which follows the John Hancock Dimensional Developed International Index. It invests in a wide range of companies from developed countries like Japan, the UK, and Germany, across many sectors. Well-known holdings include ASML Holding and Nestlé. This ETF can be useful for investors who want easy international diversification and long-term growth potential without picking individual foreign stocks. A key risk is that international stock prices can go up and down with global markets and currency changes, so the value of your investment may fluctuate.
How much will it cost me?
This ETF has an expense ratio of 0.39%, which means you’ll pay about $3.90 per year for every $1,000 you invest. That’s a bit higher than the average low-cost index ETF because it uses an actively designed multifactor strategy rather than simple passive indexing.
What would affect this ETF?
This ETF could benefit if developed markets outside North America grow steadily, especially if European and Asian economies strengthen, interest rates stabilize or fall, and sectors like financials, industrials, and major global brands such as ASML, Nestlé, and Shell continue to perform well. On the other hand, it could face challenges from slower growth or recessions overseas, rising interest rates that pressure banks and other financials, energy price swings affecting companies like Shell and TotalEnergies, or new regulations and political tensions in key international markets.
JHMD Top 10 Holdings
JHMD leans heavily on European blue chips, with ASML acting as a powerful but recently choppy engine—its longer-term strength is helping, even as near-term performance looks mixed. Energy names like Shell and TotalEnergies are rising and giving the fund a solid boost, while Nestlé and Roche provide a steadier, defensive backbone. On the flip side, financials such as BBVA and HSBC have been lagging lately, slightly dragging on returns. Overall, the ETF is broadly diversified across developed markets outside North America, but with a noticeable tilt toward European financials, industrials, and staples.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
 NL:ASML | ASML Holding NV | 1.84% | $18.57M | EUR 519.88B | 58.28% | 76Outperform |
 GB:SHEL | Shell (UK) | 1.42% | $14.38M | GBP 205.39B | 25.21% | 73Outperform |
 GB:0NQM | Vinci SA | ― | ― | ― | ― | 76Outperform |
 DE:BAYN | Bayer | 1.21% | $12.26M | EUR 56.08B | 106.93% | 54Neutral |
 CH:NESN | Nestlé SA | 1.08% | $10.93M | CHF 222.27B | 5.72% | 71Outperform |
 DE:ALV | Allianz | 1.05% | $10.63M | EUR 172.63B | 29.14% | 67Neutral |
 ES:BBVA | Banco Bilbao Vizcaya Argentaria | 1.05% | $10.58M | EUR 129.88B | 27.31% | 76Outperform |
 GB:HSBA | HSBC Holdings | 0.92% | $9.33M | GBP 229.76B | 23.30% | 80Outperform |
 RHHVF | Roche Holding AG | ― | ― | ― | ― | 73Outperform |
 CH:NOVN | Novartis AG | 0.85% | $8.62M | CHF 246.17B | 27.54% | 80Outperform |
JHMD Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For JHMD, the sentiment is Positive. The current price of 44.97 is above the 20-day moving average (MA) of 44.42, above the 50-day MA of 44.81, and above the 200-day MA of 44.25, indicating a bullish trend. The MACD of 0.03 indicates Negative momentum. The RSI at 53.90 is Neutral, neither overbought nor oversold. The STOCH value of 77.04 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JHMD.
JHMD Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| JHMD | $44.97 | $47.00(4.51% Upside) | $999.00M | 0.39% | 64Neutral |
 DBEF | $56.02 | $66.51(18.73% Upside) | $9.44B | 0.35% | 65Neutral |
 BBIN | $78.45 | $92.84(18.35% Upside) | $6.56B | 0.07% | 66Neutral |
 EFAV | $95.98 | $102.28(6.56% Upside) | $5.65B | 0.20% | 61Neutral |
 HFXI | $36.78 | $45.80(24.52% Upside) | $2.49B | 0.20% | 60Neutral |
 IHDG | $53.13 | $63.56(19.63% Upside) | $2.10B | 0.58% | 67Neutral |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| JHMD | John Hancock Multifactor Developed International ETF | 44.97 | 5.38 | 13.59% | |
| DBEF | Xtrackers MSCI EAFE Hedged Equity ETF | 56.02 | 8.88 | 18.84% | |
| BBIN | JPMorgan BetaBuilders International Equity ETF | 78.45 | 9.26 | 13.38% | |
| EFAV | iShares MSCI EAFE Min Vol Factor ETF | 95.98 | 12.43 | 14.88% | |
| HFXI | IQ 50 Percent Hedged FTSE International ETF | 36.78 | 5.56 | 17.81% | |
| IHDG | WisdomTree International Hedged Quality Dividend Growth Fund | 53.13 | 6.50 | 13.93% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.